Surveillance of Rotavirus Gastroenteritis in Children <5 Years
Information source: Soroka University Medical Center
ClinicalTrials.gov processed this data on August 23, 2015
Link to the current ClinicalTrials.gov record.
Condition(s) targeted: Gastroenteritis; Rotavirus Infections
Phase: N/A
Status: Recruiting
Sponsored by: Soroka University Medical Center
Summary
The purpose of this study is to monitor diarrheal disease and observe changes after the
introduction of the rota vaccine.
Clinical Details
Official title: Surveillance of Rotavirus Gastroenteritis Among Children <5 Years of Age Visiting the Pediatric Emergency Room in Southern Israel
Study design: Observational Model: Ecologic or Community, Time Perspective: Prospective
Primary outcome: epidemiology of rota virus disease in southern Israel before and after the rota virus vaccine introduction
Secondary outcome: To compare rotavirus gastroenteritis among children <5 years of age from Jewish and Bedouin populations.
Detailed description:
Monitoring of diarrheal disease and observe changes after the introduction of the rota
vaccine Comparing the epidemiology in Jewish and Bedouin population before and after the
introduction of the rota vaccine into the national immunization program
Eligibility
Minimum age: N/A.
Maximum age: 5 Years.
Gender(s): Both.
Criteria:
Inclusion Criteria:
1. Children < 5 years with
2. Gastro enteritis
3. Visiting the ER
4. Residents of southern Israel
5. Signed informed concent -
Exclusion Criteria:
Not all of the above
Locations and Contacts
Pediatric infectious disease unit Soroka U medical center, Beer Sheva 84101, Israel; Recruiting
David Greenberg, MD, Phone: 97286400547, Email: dudi@bgu.ac.il
Oshrit Sabach, Phone: 97286400547, Email: sabacho@bgu.ac.il
Ron Dagan, MD, Principal Investigator
Additional Information
Starting date: October 2005
Last updated: May 31, 2011
|
